StockData

Chemed Corp (CHE) stock

CHENYSEServices-Home Health Care ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 17/306% above fair value
$546.72−0.03 (-0.01%)

Close on Nov 18, 2026Market cap $7.12BP/E 26.1Yield 0.40%

Chemed net income

Net income is the profit left for shareholders after every expense, interest and tax.

Chemed's net income for the twelve months ending Sep 30, 2026 was $282.40M, up 1.3% year over year. For fiscal 2025 it was $265.24M, down 12.2% from the year before. Over ten years it grew 9.2% a year on average. The highest annual figure on record is $319.47M in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$265.24M-12.2%
FY2024Dec 31, 2024$302.00M+10.8%
FY2023Dec 31, 2023$272.51M+9.2%
FY2022Dec 31, 2022$249.62M-7.0%
FY2021Dec 31, 2021$268.55M-15.9%
FY2020Dec 31, 2020$319.47M+45.3%
FY2019Dec 31, 2019$219.92M+7.0%
FY2018Dec 31, 2018$205.54M+109.4%
FY2017Dec 31, 2017$98.18M-9.7%
FY2016Dec 31, 2016$108.74M-1.4%
FY2015Dec 31, 2015$110.27M+11.0%
FY2014Dec 31, 2014$99.32M+28.6%
FY2013Dec 31, 2013$77.23M-13.5%
FY2012Dec 31, 2012$89.30M+3.9%
FY2011Dec 31, 2011$85.98M+5.1%
FY2010Dec 31, 2010$81.83M+10.9%
FY2009Dec 31, 2009$73.78M+9.7%
FY2008Dec 31, 2008$67.28M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$71.65M+11.5%
Q2 FY2026Jun 30, 2026$67.70M+29.0%
Q1 FY2026Mar 31, 2026$66.30M-7.6%
Q4 FY2025Dec 31, 2025$76.75M-15.0%
Q3 FY2025Sep 30, 2025$64.24M-15.2%
Q2 FY2025Jun 30, 2025$52.49M-25.9%
Q1 FY2025Mar 31, 2025$71.76M+10.4%
Q4 FY2024Dec 31, 2024$90.32M+0.3%
Q3 FY2024Sep 30, 2024$75.78M+1.1%
Q2 FY2024Jun 30, 2024$70.89M+32.8%
Q1 FY2024Mar 31, 2024$65.02M+20.1%
Q4 FY2023Dec 31, 2023$90.05M+45.0%
Q3 FY2023Sep 30, 2023$74.96M+31.8%
Q2 FY2023Jun 30, 2023$53.38M-19.7%
Q1 FY2023Mar 31, 2023$54.12M-15.7%
Q4 FY2022Dec 31, 2022$62.13M-16.7%
Q3 FY2022Sep 30, 2022$56.87M-21.0%
Q2 FY2022Jun 30, 2022$66.46M+17.6%
Q1 FY2022Mar 31, 2022$64.17M-1.9%
Q4 FY2021Dec 31, 2021$74.63M-34.4%
Q3 FY2021Sep 30, 2021$72.00M+6.3%
Q2 FY2021Jun 30, 2021$56.52M-31.2%
Q1 FY2021Mar 31, 2021$65.40M+17.0%
Q4 FY2020Dec 31, 2020$113.75M+73.5%
Q3 FY2020Sep 30, 2020$67.72M+14.9%
Q2 FY2020Jun 30, 2020$82.10M+61.8%
Q1 FY2020Mar 31, 2020$55.89M+25.1%
Q4 FY2019Dec 31, 2019$65.58M+20.7%
Q3 FY2019Sep 30, 2019$58.95M+15.0%
Q2 FY2019Jun 30, 2019$50.73M-7.7%
Q1 FY2019Mar 31, 2019$44.67M-0.7%
Q4 FY2018Dec 31, 2018$54.33M-0.4%
Q3 FY2018Sep 30, 2018$51.25M+44.6%
Q2 FY2018Jun 30, 2018$54.97M–
Q1 FY2018Mar 31, 2018$45.00M+50.8%
Q4 FY2017Dec 31, 2017$54.55M+69.5%
Q3 FY2017Sep 30, 2017$35.44M–
Q2 FY2017Jun 30, 2017-$21.66M–
Q1 FY2017Mar 31, 2017$29.84M–
Q4 FY2016Dec 31, 2016$32.19M–

More Chemed figures

See a number that looks wrong?